Bilanzen Pharma und Biotech:Umsatzstark und forschungsintensiv

Key Points

• The aim is to analyze the annual financial performance of pharmaceutical and biotech companies based outside Germany in 2025.
• Examine financial reports from various pharmaceutical and biotech companies in 2025.
• Compare revenue figures to previous years to assess growth trends.
• Several companies exceeded previous year revenues in 2025.
• Growth indicates a strong market presence and ongoing investment in research.